Micropoint Biotechnologies

Micropoint Biotechnologies Co., Ltd., founded in 2007 and based in Shenzhen, China, specializes in the research, development, manufacturing, and marketing of microfluidic devices for medical applications. The company focuses on Labs-on-a-Chip products utilizing MEMS and microfluidic technologies to deliver rapid and cost-effective point-of-care diagnostic solutions that enhance patient care. With a global presence supported by over 100 distribution partners and manufacturing facilities in Shenzhen and the United States, Micropoint is certified under GMP and ISO 13485 standards. The company employs between 200-500 people and has reported revenues of approximately $6.1 million. Its core offerings include point-of-care testing systems, such as the qLabs Monitoring System for anticoagulation therapy, cardiovascular diagnostics, infectious disease testing, and COVID-19 rapid tests. Micropoint also provides customized microfluidic device development and solutions for healthcare providers, hospitals, and patients, aiming to improve clinical outcomes and patient management.

• Employees 29
• Founded 2007
• Annual Revenue $5000000
• Total Funding $108950000